RE-LY Heart Failure Subgroup Bleeding Score Calculator
Patient assessment
Use the patient's current clinical information.
How to interpret these scores
Bleeding scores can help structure review of modifiable risk factors but should not be used alone to withhold anticoagulation. The scores were developed in atrial-fibrillation populations and their performance may differ by treatment, comorbidity, and clinical setting.
Risk-reduction checklist
- Improve blood-pressure control and review renal and hepatic function.
- Confirm the indication and duration for antiplatelet therapy; avoid unnecessary combination antithrombotic treatment.
- Review NSAIDs, alcohol use, anemia, prior bleeding, and falls.
- For vitamin K antagonist therapy, assess INR control and time in therapeutic range.
- Reassess risk factors over time and apply clinical judgement to the individual patient.
Important limitations
The input set does not capture every variable in the original derivation datasets. HAS-BLED drug exposure is represented by antiplatelet and NSAID selections; ORBIT uses antiplatelet therapy specifically. The anemia definition here uses hemoglobin only, not hematocrit or history of anemia. Treat outputs as a bedside approximation when these data are unavailable.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.